Sanofi’s Plavix Faces Price Cut Of Nearly Half In China
This article was originally published in PharmAsia News
Executive Summary
A notice issued by the Shanxi Medical Institutes Drug Procurement Center on May 31 set the price for Sanofi’s Plavix (clopidogrel) at RMB 65.3 ($10.63), a cut of 47% from RMB 119 set in in 2011 when it was a non-essential drug.